EMA approves Sanofi’s Dupixent for COPD treatment in adults
The EMA has granted approval to Sanofi's Dupixent for adults with uncontrolled chronic obstructive pulmonary disease (COPD).
The EMA has granted approval to Sanofi's Dupixent for adults with uncontrolled chronic obstructive pulmonary disease (COPD).
What's Your Reaction?
